HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ning Jiang Selected Research

Enzymes

6/2022Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management.
3/2022Comparative analysis of ketone body metabolism in BALB/c mice infected with Trypanosoma evansi and Toxoplasma gondii.
11/2021The pivotal role of the NLRC4 inflammasome in neuroinflammation after intracerebral hemorrhage in rats.
1/2017RNAi-mediated silencing of NOX4 inhibited the invasion of gastric cancer cells through JAK2/STAT3 signaling.
12/2014PfRON3 is an erythrocyte-binding protein and a potential blood-stage vaccine candidate antigen.
6/2013Misleading Elevation of Troponin T caused by Polymyositis.
1/2013A-methylacyl-CoA racemase (AMACR) and prostate-cancer risk: a meta-analysis of 4,385 participants.
4/2012Prevalence of syphilis infection in different tiers of female sex workers in China: implications for surveillance and interventions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ning Jiang Research Topics

Disease

70Neoplasms (Cancer)
06/2022 - 06/2002
34Infections
11/2021 - 01/2010
27Prostatic Neoplasms (Prostate Cancer)
10/2021 - 09/2010
19Inflammation (Inflammations)
06/2022 - 03/2005
18Neoplasm Metastasis (Metastasis)
01/2022 - 06/2002
16Malaria
11/2022 - 07/2010
16Nasopharyngeal Carcinoma
01/2022 - 04/2012
14Urinary Bladder Neoplasms (Bladder Cancer)
10/2022 - 07/2013
9Neuroinflammatory Diseases
05/2022 - 01/2010
9Carcinogenesis
12/2021 - 09/2009
8Hepatocellular Carcinoma (Hepatoma)
06/2022 - 01/2018
8Stroke (Strokes)
01/2019 - 12/2011
7Cognitive Dysfunction
03/2022 - 06/2018
6Toxoplasmosis
01/2021 - 09/2012
6Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2014
6Renal Cell Carcinoma (Grawitz Tumor)
12/2020 - 09/2009
5Mitochondrial Diseases (Mitochondrial Disease)
12/2021 - 01/2014
5Hypoxia (Hypoxemia)
01/2021 - 06/2008
5Squamous Cell Carcinoma of Head and Neck
12/2018 - 07/2014
5Lymphatic Metastasis
01/2018 - 01/2013
4Sleep Deprivation
05/2022 - 01/2018
4Heart Failure
01/2022 - 01/2018
4Brain Ischemia (Cerebral Ischemia)
01/2022 - 05/2013
4Adenocarcinoma of Lung
12/2021 - 01/2016
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2021 - 01/2016
4Tetraploidy
01/2020 - 02/2010
4Body Weight (Weight, Body)
10/2018 - 01/2015
4HIV Infections (HIV Infection)
01/2018 - 12/2011
4Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2017 - 01/2015
4Syphilis
05/2015 - 04/2012
3Hemorrhage
02/2022 - 01/2019
3Schistosomiasis (Bilharziasis)
01/2022 - 10/2010
3Reperfusion Injury
01/2022 - 05/2013
3Glioma (Gliomas)
01/2022 - 01/2020
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2021
3Cerebral Infarction
01/2022 - 05/2013
3Brain Edema (Cerebral Edema)
11/2021 - 01/2021
3Hyperplasia
01/2019 - 01/2014
3Breast Neoplasms (Breast Cancer)
01/2018 - 06/2002
2Rheumatoid Arthritis
11/2022 - 10/2021
2COVID-19
11/2022 - 01/2022
2Chronic Disease (Chronic Diseases)
11/2022 - 08/2014
2Wounds and Injuries (Trauma)
07/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

36Proteins (Proteins, Gene)FDA Link
06/2022 - 08/2006
18Biomarkers (Surrogate Marker)IBA
11/2022 - 06/2012
15Pharmaceutical PreparationsIBA
02/2021 - 08/2006
14MicroRNAs (MicroRNA)IBA
10/2022 - 06/2012
13AntigensIBA
01/2022 - 10/2010
11VaccinesIBA
11/2022 - 07/2010
10Biological ProductsIBA
01/2022 - 04/2003
9AndrogensIBA
07/2021 - 05/2012
8EnzymesIBA
06/2022 - 04/2012
8Messenger RNA (mRNA)IBA
01/2022 - 04/2013
8Long Noncoding RNAIBA
12/2021 - 01/2018
6Neuroprotective AgentsIBA
05/2022 - 05/2013
62- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
01/2022 - 12/2011
6RNA (Ribonucleic Acid)IBA
11/2021 - 01/2016
6Circular RNAIBA
10/2021 - 10/2018
6AntibodiesIBA
01/2017 - 10/2010
5Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 01/2017
5LipopolysaccharidesIBA
06/2022 - 10/2020
5CytokinesIBA
06/2022 - 01/2014
5InflammasomesIBA
01/2022 - 01/2020
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2013
4InterferonsIBA
11/2022 - 01/2018
4Androgen Receptors (Androgen Receptor)IBA
10/2021 - 09/2015
4Neurotransmitter Agents (Neurotransmitter)IBA
07/2021 - 01/2020
4CateninsIBA
02/2021 - 01/2015
4Scopolamine (Hyoscine)FDA Link
01/2021 - 06/2018
4Small Interfering RNA (siRNA)IBA
01/2021 - 01/2010
4Interleukin-6 (Interleukin 6)IBA
10/2020 - 02/2015
4Immunoglobulin G (IgG)IBA
01/2020 - 10/2010
4DNA (Deoxyribonucleic Acid)IBA
12/2015 - 06/2002
3Deubiquitinating EnzymesIBA
06/2022 - 01/2015
3Glucose (Dextrose)FDA LinkGeneric
06/2022 - 04/2018
3IsoflavonesIBA
05/2022 - 06/2018
3Sirtuin 1IBA
01/2022 - 01/2020
3Oxygen (Dioxygen)IBA
01/2022 - 03/2020
3NucleotidesIBA
01/2022 - 03/2020
3CaspasesIBA
12/2021 - 05/2012
3ImmunosorbentsIBA
11/2021 - 04/2012
3InterleukinsIBA
11/2021 - 01/2018
3Antimalarials (Antimalarial Agents)IBA
01/2021 - 01/2020
3ORALIT (ORS)IBA
01/2021 - 01/2015
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 10/2020
3ArtesunateIBA
10/2020 - 01/2020
3Hormones (Hormone)IBA
01/2019 - 01/2014
3Vascular Endothelial Growth Factor CIBA
01/2018 - 01/2013
3Nucleosomes (Nucleosome)IBA
05/2012 - 02/2003
3Caspase 3 (Caspase-3)IBA
09/2009 - 06/2002
2artenimol (dihydroartemisinin)IBA
11/2022 - 05/2020
2Dinoprostone (PGE2)FDA Link
06/2022 - 02/2015

Therapy/Procedure

20Therapeutics
03/2022 - 09/2009
9Castration
01/2019 - 01/2014
7Radiotherapy
01/2020 - 10/2014
6Immunotherapy
01/2022 - 01/2017
5Aftercare (After-Treatment)
05/2022 - 07/2014
5Drug Therapy (Chemotherapy)
02/2021 - 11/2009
3Chemoradiotherapy
01/2020 - 09/2017
3Lithotripsy (Extracorporeal Shockwave Lithotripsy)
01/2019 - 01/2010